Seek Returns

Pfizer (PFE) Stock Analysis

This is a peer-relative look at Pfizer (PFE): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Pharmaceuticals, Biotechnology & Life Sciences peers, so every number reads in context rather than in isolation.

Company Profile

Company profile fields for Pfizer (PFE)
Profile ItemPFE
NamePfizer Inc.
Country/RegionUnited States
GICS SectorHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
GICS Sub-IndustryPharmaceuticals
Market Capitalization167.52 billion USD
CurrencyUSD
ExchangeNYSE
Listing DateJune 1, 1972
Security TypeCommon Stock

Price Performance

Cumulative Growth

PFE
GSPC
Loading price history…
Pfizer (PFE) vs. S&P 500 (GSPC): Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Pfizer (PFE) and S&P 500 (GSPC). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Pfizer (PFE) and S&P 500 (GSPC). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Pfizer (PFE) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: PFEIndustry group median
Total Return (1Y)28.65%24.62%
Total Return (3Y, Annualized)6.41%20.37%
Total Return (5Y, Annualized)-3.98%-4.02%

Risk Profile

Drawdown History

PFE
GSPC
Loading price history…
Pfizer (PFE) vs. S&P 500 (GSPC): Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Pfizer (PFE) and S&P 500 (GSPC). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Pfizer (PFE) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: PFEIndustry group median
Volatility (1Y, Annualized)21.72%66.36%
Beta (5Y)0.350.93
Max Drawdown (5Y)-58.96%-80.19%

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
Each dot is a stock plotted by 1-year volatility (risk) and 1-year return. PFE is highlighted; the dashed line is the Capital Allocation Line from the risk-free rate through the industry median — dots above it are stronger on a risk-adjusted basis.

Risk-Adjusted Metrics

Pfizer (PFE) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: PFEIndustry group median
Sharpe Ratio (1Y)1.120.36
Sortino Ratio (1Y)1.730.58

Profitability

ROE (TTM)

Pfizer (PFE) posts ROE of 4.47%, roughly around the peer group’s normal range. Shareholders’ equity is producing a return that looks broadly typical for the industry.

PFE

Pharmaceuticals, Biotechnology & Life Sciences industry group

4.47%

Group distribution
Max
109.18%
Q3
6.23%
PFE
4.47%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Largest peers
LLY
86.02%
NVS
24.33%
AZN
22.57%
JNJ
20.02%
MRK
5.06%
PFE
4.47%
ABBV
--
Loading chart…
Where Pfizer (PFE) stands on ROE within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Net Margin (TTM)

Pfizer (PFE) keeps 6.34% of revenue as net profit, putting net margin in the upper peer quartile. After operating costs, interest, and taxes, more of each sales dollar reaches shareholders than it does at most industry peers.

PFE

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.34%

Group distribution
Max
18.05%
PFE
6.34%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Largest peers
LLY
31.90%
AZN
17.68%
NVS
17.49%
JNJ
16.20%
ABBV
15.67%
PFE
6.34%
MRK
3.64%
Loading chart…
Where Pfizer (PFE) stands on net margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Operating Margin (TTM)

Pfizer (PFE) turns 33.38% of revenue into operating profit, putting operating margin in the upper peer quartile. Before financing and taxes enter the picture, the day-to-day business keeps more of each sales dollar than most industry peers.

PFE

Pharmaceuticals, Biotechnology & Life Sciences industry group

33.38%

Group distribution
Max
83.12%
PFE
33.38%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Largest peers
LLY
53.66%
ABBV
39.59%
MRK
35.22%
NVS
34.27%
PFE
33.38%
AZN
29.57%
JNJ
25.74%
Loading chart…
Where Pfizer (PFE) stands on operating margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Profitability Metrics

Pfizer (PFE) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: PFEIndustry group median
ROE (TTM)4.47%-26.66%
ROA (TTM)5.59%-12.50%
Net Margin (TTM)6.34%0.00%
Operating Margin (TTM)33.38%0.00%
Gross Margin (TTM)74.90%37.87%

Growth

Revenue Growth

Pfizer (PFE) grew revenue -1.65%, in the lower peer quartile. The top line is expanding more slowly than at most peers, which can reflect softer demand, lost share, or weaker pricing.

Loading chart…
Pfizer (PFE): Revenue Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

EPS Growth

Pfizer (PFE) grew earnings per share -3.55%, roughly around the peer group's normal range. Bottom-line momentum looks broadly typical for the industry.

Loading chart…
Pfizer (PFE): EPS Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

Growth Metrics

Pfizer (PFE) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: PFEIndustry group median
Revenue Growth (YoY)-1.65%11.45%
Revenue Growth (3Y CAGR)-14.80%9.94%
EPS Growth (YoY)-3.55%4.28%
EPS Growth (3Y CAGR)-37.12%4.17%

Financial Strength

Current Ratio (MRQ)

Pfizer (PFE) has current ratio of 1.42, in the tighter-liquidity quartile for its industry. The short-term cushion is thinner than most peers carry, even if the absolute comfort level still depends on the business model.

PFE

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.42

Group distribution
Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
PFE
1.42
Min
0.10
Largest peers
PFE
1.42
LLY
1.39
MRK
1.35
JNJ
1.02
AZN
1.01
NVS
0.88
ABBV
0.87
Loading chart…
Where Pfizer (PFE) stands on current ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Debt / Equity (MRQ)

Pfizer (PFE) has debt-to-equity ratio of 0.71, in the higher-leverage quartile for its industry. The heavier reliance on borrowing can make earnings, rates, or refinancing conditions matter more.

PFE

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.71

Group distribution
Max
1.42
PFE
0.71
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
Largest peers
NVS
1.29
LLY
1.23
MRK
1.20
PFE
0.71
AZN
0.66
JNJ
0.55
ABBV
--
Loading chart…
Where Pfizer (PFE) stands on debt-to-equity ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Financial Strength Metrics

Pfizer (PFE) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: PFEIndustry group median
Current Ratio (MRQ)1.425.52
Debt / Equity (MRQ)0.710.15
Net Debt / EBITDA1.971.08

Dividends

Dividend Yield (TTM)

Pfizer (PFE) has dividend yield of 7.30%, above the entire industry range. That headline income is large, but yields this far above peers often come from a falling share price or an at-risk payout, so dividend safety matters more than the percentage itself.

PFE

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.30%

Group distribution
PFE
7.30%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Largest peers
PFE
7.30%
NVS
2.88%
ABBV
2.40%
MRK
2.29%
JNJ
1.94%
AZN
1.73%
LLY
0.49%
Loading chart…
Where Pfizer (PFE) stands on dividend yield within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Payout Ratio (TTM)

Pfizer (PFE) has payout ratio of 245.71%, meaning dividends exceeded current-period earnings. The gap would need to be covered by cash, retained earnings, financing, or other sources, so earnings alone do not support the payout.

PFE

Pharmaceuticals, Biotechnology & Life Sciences industry group

245.71%

Group distribution
PFE
245.71%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Largest peers
MRK
343.43%
PFE
245.71%
ABBV
117.35%
NVS
90.46%
JNJ
80.12%
AZN
45.38%
LLY
21.71%
Loading chart…
Where Pfizer (PFE) stands on payout ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Metrics

Pfizer (PFE) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: PFEIndustry group median
Dividend Yield (TTM)7.30%0.00%
Dividend Payout Ratio (TTM)245.71%0.00%

Valuation

P/E Ratio (TTM)

Pfizer (PFE) trades at P/E ratio of 41.99, near the industry’s usual earnings multiple. The stock is not showing a clear peer discount or premium on trailing earnings.

PFE

Pharmaceuticals, Biotechnology & Life Sciences industry group

41.99

Group distribution
Max
85.34
Q3
43.46
PFE
41.99
Median
26.69
Q1
13.30
Min
0.07
Largest peers
MRK
148.21
ABBV
50.05
LLY
43.95
PFE
41.99
JNJ
41.92
NVS
31.02
AZN
26.37
Loading chart…
Where Pfizer (PFE) stands on P/E ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/S Ratio (TTM)

Pfizer (PFE) trades at 2.63 on P/S ratio, in the lower sales-valuation quartile for its industry. That points to a cheaper revenue stream than most peers, with margin quality still doing the heavy lifting.

PFE

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.63

Group distribution
Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
PFE
2.63
Min
0.01
Largest peers
LLY
13.95
ABBV
7.80
JNJ
6.69
MRK
5.37
NVS
5.35
AZN
4.63
PFE
2.63
Loading chart…
Where Pfizer (PFE) stands on P/S ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/B Ratio (MRQ)

Pfizer (PFE) trades at 1.88 on P/B ratio, roughly in line with the industry’s normal price-to-book range. Its balance sheet is not being priced at a clear discount or premium versus peers.

PFE

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.88

Group distribution
Max
13.53
Q3
6.54
Median
3.25
PFE
1.88
Q1
1.69
Min
-5.59
Largest peers
LLY
29.96
NVS
8.25
JNJ
8.16
MRK
8.06
AZN
5.59
PFE
1.88
ABBV
-112.34
Loading chart…
Where Pfizer (PFE) stands on P/B ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Valuation Metrics

Pfizer (PFE) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: PFEIndustry group median
P/E Ratio (TTM)41.9926.69
P/S Ratio (TTM)2.637.30
P/B Ratio (MRQ)1.883.25
Free Cash Flow Yield (TTM)7.76%-1.66%